Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Cancer Discovery
|
June 1, 2022
Can Drug Repurposing Accelerate Precision Oncology?
Luuk J Schipper, Laurien J Zeverijn, Mathew J Garnett, et al.
Cell Reports
|
May 7, 2020
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine
Krijn K Dijkstra, Kim Monkhorst, Luuk J Schipper, et al.
Cancers
|
January 21, 2022
Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients
Luuk J Schipper, Kim Monkhorst, Kris G Samsom, et al.
BMC Medical Genomics
|
November 10, 2020
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)
Kris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.
Cancer Discovery
|
April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
Gabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
November 25, 2023
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics
Roelof Koster, Luuk J Schipper, Noor A A Giesbertz, et al.
The Journal of Pathology
|
July 6, 2022
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice
Kris G Samsom, Luuk J Schipper, Paul Roepman, et al.
Nature Protocols
|
December 13, 2023
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice
Kris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Cancer Discovery
|
June 1, 2022
Can Drug Repurposing Accelerate Precision Oncology?
Luuk J Schipper, Laurien J Zeverijn, Mathew J Garnett, et al.
Cell Reports
|
May 7, 2020
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine
Krijn K Dijkstra, Kim Monkhorst, Luuk J Schipper, et al.
Cancers
|
January 21, 2022
Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients
Luuk J Schipper, Kim Monkhorst, Kris G Samsom, et al.
BMC Medical Genomics
|
November 10, 2020
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)
Kris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.
Cancer Discovery
|
April 10, 2021
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
Gabriele Picco, Chiara M Cattaneo, Esmée J van Vliet, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
November 25, 2023
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics
Roelof Koster, Luuk J Schipper, Noor A A Giesbertz, et al.
The Journal of Pathology
|
July 6, 2022
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice
Kris G Samsom, Luuk J Schipper, Paul Roepman, et al.
Nature Protocols
|
December 13, 2023
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice
Kris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.
Page
of 1